Otago signs exclusive agreement with Biofile Diagnostics for Middle Eastern Expansion
Official launch of IPC Pharma Limited in the UK held at Danish Embassy, London
September 1, 2008Otago Healthcare and Global Healthcare FZ sign collaboration agreement
February 1, 2009Otago signs exclusive agreement with Biofile Diagnostics for Middle Eastern Expansion
Biofile Diagnostics based in Turku signs exclusive agreement with Otago Healthcare to evaluate market for key products for launch in the United Kingdom in Q2 2009.
The initial market evaluation will be to assess the potential for Biofile IVD kits for detecting Celica disease and products early detection of Lactose intolerance and diabetes.
Dr Vesa Kleimola , CEO (Biofile Diagnostics) commented:-
We look forward to working with Otago Healthcare in the coming months with our range of products for early detection of disease. We are pleased to be in partnership with Otago who have demonstrated their depth and reach in key markets for us.